Clinical Trial Update: Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating doxycycline in combination with interferon-B-1a for multiple sclerosis has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Doxycycline (Doxycycline)
• Interferon-B-1a (interferon beta-1a)

Snippet

Sponsor: Louisiana State University Health Sciences Center Shreveport | Conditions: Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2011-11-17